PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportscardiovascular diseases
MeSH D002318 - cardiovascular diseases
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D002318: 
Cardiovascular diseases
$
Success rate
D006331:Heart diseases
0 Companies
0 Drugs
Success rate
D011249:Cardiovascular pregnancy complications
0 Companies
0 Drugs
Success rate
D014652:Vascular diseases
$
Success rate
D018376:Cardiovascular abnormalities
0 Companies
0 Drugs
Success rate
D053821:Cardiovascular infections
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
SandozFolic acid, Dexpanthenol, Ascorbic acid, Cyanocobalamin, Vitamin a, Alpha-tocopherol, Biotin, Cholecalciferol, Niacinamide, Pyridoxine, Riboflavin, Thiamine, Tocopherol Infuvite  2000-05-18   
OrganonAlendronate, Cholecalciferol Fosamax D  2005-04-07   
Clinical Trials
Historical Success Rate
Phase 1
66%
41/62
Phase 2
76%
84/110
Phase 3
41%
68/164
Approved: 3Overall Success rate: 21%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Organon
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use